Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -92.16% is 34% above its 5-year average of -140.28%, near the high end of its 5-year range (-993.24%–-57.40%).
As of the fiscal period ended Tuesday, June 30, 2026. 74.86% above its 12-month average of -366.59%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -92.16%.
RETURN ON INVESTED CAPITAL (ROIC)
-92.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-366.59%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-297.25%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-140.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-121.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+74.86%
CURRENT VS 3Y AVG
+69.00%
CURRENT VS 5Y AVG
+34.30%
CURRENT VS 10Y AVG
+24.02%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.10%
median of 677 covered companies
CURRENT VS SECTOR MEDIAN
-170.27%
vs the sector median at left
Immunic, Inc.
Market Cap
$110.27M
Return on Invested Capital (ROIC)
-92.16%
TTM Avg
-366.59%
3Y Avg
-297.25%
5Y Avg
-140.28%
Market Cap
$110.95M
Return on Invested Capital (ROIC)
-97.99%
TTM Avg
-45.11%
3Y Avg
-60.38%
5Y Avg
-60.38%
Market Cap
$109.73M
Return on Invested Capital (ROIC)
-47.54%
TTM Avg
-30.79%
3Y Avg
-47.42%
5Y Avg
-44.72%
Market Cap
$109.62M
Return on Invested Capital (ROIC)
-352.19%
TTM Avg
-1462.52%
3Y Avg
-874.13%
5Y Avg
-711.22%
Market Cap
$108.94M
Return on Invested Capital (ROIC)
-101.30%
TTM Avg
-45.83%
3Y Avg
-127.78%
5Y Avg
-123.84%
Market Cap
$108.48M
Return on Invested Capital (ROIC)
-34.77%
TTM Avg
-10.04%
3Y Avg
-11.68%
5Y Avg
-11.21%
Market Cap
$110.33M
Return on Invested Capital (ROIC)
-6.84%
TTM Avg
-23.14%
3Y Avg
-32.81%
5Y Avg
-31.36%
Market Cap
$114.08M
Return on Invested Capital (ROIC)
-19.83%
TTM Avg
-23.34%
3Y Avg
-19.01%
5Y Avg
-18.39%
Market Cap
$115.36M
Return on Invested Capital (ROIC)
-145.10%
TTM Avg
-158.49%
3Y Avg
-239.94%
5Y Avg
-201.97%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunic, Inc. (IMUX) | $110.27M | -92.16% | -366.59% | -297.25% | -140.28% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $110.95M | -97.99% | -45.11% | -60.38% | -60.38% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $109.73M | -47.54% | -30.79% | -47.42% | -44.72% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $109.62M | -352.19% | -1462.52% | -874.13% | -711.22% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.94M | -101.30% | -45.83% | -127.78% | -123.84% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $108.48M | -34.77% | -10.04% | -11.68% | -11.21% |
| Apyx Medical Corporation (APYX)vs › | $110.33M | -6.84% | -23.14% | -32.81% | -31.36% |
| MaxCyte, Inc. (MXCT)vs › | $114.08M | -19.83% | -23.34% | -19.01% | -18.39% |
| Lucid Diagnostics Inc. (LUCD)vs › | $115.36M | -145.10% | -158.49% | -239.94% | -201.97% |
| BGM Group Ltd. (BGM)vs › | $111.14M | -3.19% | -2.23% | -1.75% | 1.24% |
ROIC
-92.2%
ROE
-87.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -92.16% |
| 2026-03-31 | -72.43% |
| 2025-09-30 | -993.24% |
| 2025-06-30 | -308.55% |
| 2024-12-31 | -524.54% |
| 2024-09-30 | -231.38% |
| 2024-06-30 | -146.75% |
| 2024-03-31 | -114.10% |
| 2023-12-31 | -335.55% |
| 2023-09-30 | -267.10% |
| 2023-06-30 | -184.00% |
| 2023-03-31 | -135.36% |
| 2022-12-31 | -104.20% |
| 2022-09-30 | -76.56% |
| 2022-06-30 | -63.87% |
| 2022-03-31 | -58.29% |
| 2021-12-31 | -71.78% |
| 2021-09-30 | -57.40% |
| 2021-06-30 | -65.22% |
| 2021-03-31 | -52.28% |
| 2020-12-31 | -30.71% |
| 2020-09-30 | -26.26% |
| 2020-06-30 | -48.57% |
| 2020-03-31 | -81.21% |
| 2019-12-31 | -71.20% |
| 2019-09-30 | -59.91% |
| 2019-06-30 | -56.41% |
| 2019-03-31 | -409.82% |
| 2018-12-31 | -337.05% |
| 2018-09-30 | -379.47% |
| 2018-06-30 | -206.88% |
| 2018-03-31 | -145.84% |
| 2017-12-31 | -105.09% |
| 2017-09-30 | -80.00% |
| 2017-06-30 | -64.46% |
| 2017-03-31 | -52.42% |
| 2016-12-31 | -70.48% |
| 2016-09-30 | -57.97% |
| 2016-06-30 | -55.86% |
| 2016-03-31 | -60.12% |
| 2015-12-31 | -63.23% |
| 2015-09-30 | -95.62% |
| 2015-06-30 | -81.15% |
| 2015-03-31 | -63.45% |
| 2014-12-31 | -51.47% |
| 2014-09-30 | -60.22% |
| 2014-06-30 | -47.99% |
| 2014-03-31 | -81.64% |
| 2013-12-31 | -75.23% |
| 2013-09-30 | -80.85% |
| 2013-06-30 | -48.72% |
